| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
|---|---|---|
| Report Filing | 2022-11-10 | 2022-03-31 |
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 0 |
| Gross Profit | 0 | 0 |
| Operating Expenses | 1.02 | 0.899 |
| Research & Development | 0 | 0 |
| Selling, General and Administrative | 1.02 | 0.899 |
| Other Operating Expenses | -0 | -0 |
| Operating Income | -1.02 | -0.899 |
| Net Non-Operating Interest | 0 | 0.011 |
| Interest Income | 1.29 | 0.011 |
| Interest Expense | 1.29 | 0 |
| Equity & Other Income/(Expense) | 6.32 | 2.73 |
| Income Before Tax | 5.3 | 1.84 |
| Income Tax Expense | -7.61 | -0.011 |
| Income Attributable to Non-Controlling Interest | 0 | 0.011 |
| Net Income | 12.9 | 1.84 |
| Depreciation and Amortization | -4.28 | -2.73 |
| EBITDA | -5.3 | -3.63 |
| Earnings Per Share (EPS) | 0.431 | 0.07 |
| Diluted Earnings Per Share | 0.431 | 0.07 |
| Weighted Average Shares Outstanding | 29.41 | 25.24 |
| Diluted Weighted Average Shares Outstanding | 29.41 | 25.24 |
